| scholarly article | Q13442814 |
| P50 | author | Abrar A Qureshi | Q114301950 |
| Shaowei Wu | Q60057720 | ||
| P2093 | author name string | Qi Sun | |
| Jiali Han | |||
| Wen-Qing Li | |||
| P2860 | cites work | Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women | Q70040221 |
| Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis | Q79190342 | ||
| Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis | Q79305514 | ||
| Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey | Q80811998 | ||
| Efficacy of simvastatin in plaque psoriasis: A pilot study | Q80813778 | ||
| Psoriasis | Q81716559 | ||
| Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 | ||
| Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime | Q28212769 | ||
| Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire | Q33750434 | ||
| Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure | Q33847589 | ||
| Smoking and risk of incident psoriatic arthritis in US women | Q34266162 | ||
| Obesity and risk of incident psoriatic arthritis in US women | Q34283211 | ||
| A prospective study of risk factors for pulmonary embolism in women | Q34417008 | ||
| The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat | Q34505900 | ||
| The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. | Q34567542 | ||
| Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study. | Q34590463 | ||
| Triggering psoriasis: the role of infections and medications | Q34714632 | ||
| Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide | Q34956672 | ||
| Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis | Q35086458 | ||
| Statins: novel additions to the dermatologic arsenal? | Q35798211 | ||
| Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis | Q35896544 | ||
| Hypercholesterolemia and inflammation in atherogenesis: two sides of the same coin | Q36306350 | ||
| Microvascular responses to hypercholesterolemia: the interactions between innate and adaptive immune responses | Q36566474 | ||
| Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease | Q36667311 | ||
| Pathogenesis and therapy of psoriasis | Q36742020 | ||
| The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool | Q36870281 | ||
| Pathogenesis and clinical features of psoriasis | Q36894005 | ||
| Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study | Q37095225 | ||
| CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation | Q37138961 | ||
| Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study | Q37449514 | ||
| The association between psoriasis and dyslipidaemia: a systematic review | Q38056160 | ||
| Statin use and risk of first-time psoriasis diagnosis | Q38439015 | ||
| Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). | Q44948934 | ||
| Psoriasis: cardiovascular risk factors and other disease comorbidities | Q45810812 | ||
| Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. | Q47274479 | ||
| Stroke incidence and risk factors for stroke in Copenhagen, Denmark. | Q50547636 | ||
| Development and pilot-testing of a psoriasis screening tool. | Q51816053 | ||
| Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. | Q53249650 | ||
| Epidemiology of psoriatic arthritis in the population of the United States. | Q53276933 | ||
| High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. | Q53370558 | ||
| Sex and classic risk factors after myocardial infarction: a community study | Q57540186 | ||
| Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis | Q57950813 | ||
| Prevalence of cardiovascular risk factors in patients with psoriasis | Q60711908 | ||
| P433 | issue | 2 | |
| P921 | main subject | psoriatic arthritis | Q511097 |
| hypercholesterolemia | Q762713 | ||
| P304 | page(s) | 304-310 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women | |
| P478 | volume | 66 |
| Q36143423 | Alcohol intake and risk of incident psoriatic arthritis in women |
| Q40069191 | Cardiometabolic Disorders in Psoriatic Disease |
| Q91778340 | Cardiovascular Comorbidities in Psoriatic Disease |
| Q37613277 | Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence. |
| Q37654037 | Could Psoriatic Arthritis Be Easily Diagnosed from Current Suspicious Physical Findings in the Dermatology Clinic? |
| Q33694555 | Impact of metabolic status on the incidence of psoriasis: a Korean nationwide cohort study |
| Q90650207 | Long Non-Coding RNAs Play a Role in the Pathogenesis of Psoriatic Arthritis by Regulating MicroRNAs and Genes Involved in Inflammation and Metabolic Syndrome |
| Q26778275 | Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response |
| Q90248096 | Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities |
| Q92244417 | Pediatric psoriatic arthritis: a population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities |
| Q35370653 | Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women |
| Q47400940 | Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up |
| Q36946167 | Presence of selected metabolic syndrome components in patients with psoriasis vulgaris |
| Q91451261 | Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition |
| Q46180528 | Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment |
| Q30235889 | Psoriasis and comorbid diseases: Epidemiology |
| Q34474068 | Psoriasis, psoriatic arthritis and risk of gout in US men and women |
| Q38688128 | Psoriatic arthritis: complexities, comorbidities and implications for the clinic |
| Q38983615 | Risk of depression in women with psoriasis: a cohort study |
| Q28254889 | Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists |
| Q36175115 | The Epidemiology of Psoriatic Arthritis |
| Q48148389 | The preclinical phase of PsA: a challenge for the epidemiologist |
| Q36500064 | Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis |
| Q34283073 | Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort study |
Search more.